Dapagliflozin once‐daily and exenatide once‐weekly dual therapy: A 24‐week randomized, placebo‐controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes

AIMS: To explore the effects of dual therapy with dapagliflozin and exenatide on body weight, body composition, glycaemic variables and systolic blood pressure (SBP) in obese adults without diabetes. MATERIALS AND METHODS: In this single‐centre, double‐blind trial, we randomized 50 obese adults with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lundkvist, Per, Sjöström, C. David, Amini, Sam, Pereira, Maria J., Johnsson, Eva, Eriksson, Jan W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215525/
https://www.ncbi.nlm.nih.gov/pubmed/27550386
http://dx.doi.org/10.1111/dom.12779

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5215525/
https://www.ncbi.nlm.nih.gov/pubmed/27550386
http://dx.doi.org/10.1111/dom.12779

Ejemplares similares